Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

2018 Virtual Conference for Pain and Palliative Care


This web-based conference will provide the pain and palliative care clinician with cutting edge tools that are readily applicable to practice.  

Date: Jul 17, 2018 02:00 PM - 05:00 PM

Location: Virtual

Fee

$0.00

CE Hours

3.00

CE Units

0.300

Registration closes on Jul 17, 2018 01:30 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Disclosure Policy
The disclosure policies of the SIUE School of Pharmacy Office of Continuing Professional Education requires all persons in a position to control content to disclose any relevant financial relationships with commercial interests. If a conflict is identified, the Office of Professional Continuing Education will initiate a process for resolving the conflict.  The existence of relationships does not necessarily imply bias or lessen the value of the activity.  All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The persons required to disclose conflicts include all course faculty, the SIUE CPE administrator, all activity planners and all reviewers.  The relevant commercial financial relationships or affiliations must have occured over the past 12 months.

 
Accreditation Council for Pharmacy Education
Southern Illinois University Edwardsville School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  
 
 
 
The participant must provide the correct NABP ePID number/DOB combination in their electronic profile. All CPE evaluations must be completed within 60 days of completing the activity. It is the participant's responsibility to check that their credit records are correct within the 60 day period after completion of the activity.   Log in to CPE Monitor at www.mycpemonitor.net to view a list of all ACPE-accredited activities you have taken. Any discrepancies must be resolved with the CPE Provider directly and in a timely manner.
 
 
 

 

Requirements for CE Credit

This activity is structured to meet knowledge-based
educational needs and acquire factual knowledge.
Information in knowledge-type activities is based
on evidence as accepted in the literature by the he
alth care professions. Continuing pharmacy educati
on (CPE) credit will be earned based on
participation in the activity. Attendance and part
icipation are required before obtaining CPE credit.
Any individual who is more than 10 minutes late t
o
an activity or leaves an activity early will not be
granted CPE credit. This procedure will be strict
ly enforced, so please plan accordingly. Participa
nts
must complete an activity evaluation and posttest (
if applicable) with a passing score of 70 percent o
r greater.
This activity is accredited through ACPE for pharma
cist and pharmacy technician continuing pharmacy ed
ucation credit. Even though IPhA may accredit
an activity for technicians, it is the technician’s
responsibility to determine whether the subject ma
tter is acceptable to the Pharmacy Technician
Certification Board (PTCB) for recertification.
If all requirements are met, participants will rece
ive continuing pharmacy education credit in the fol
lowing manner. Partial credit will not be awarded.
Please allow 60 days for processing.
 The activities in this conference are structured to meet knowledge-based education needs and acquire factual knowledge.  The information presented is based on evidence in accepted in health professions literature.  
 
This activity is structured to meet knowledge-based
educational needs and acquire factual knowledge.
Information in knowledge-type activities is based
on evidence as accepted in the literature by the he
alth care professions. Continuing pharmacy educati
on (CPE) credit will be earned based on
participation in the activity. Attendance and part
icipation are required before obtaining CPE credit.
Any individual who is more than 10 minutes late t
o
an activity or leaves an activity early will not be
granted CPE credit. This procedure will be strict
ly enforced, so please plan accordingly. Participa
nts
must complete an activity evaluation and posttest (
if applicable) with a passing score of 70 percent o
r greater.
This activity is accredited through ACPE for pharma
cist and pharmacy technician continuing pharmacy ed
ucation credit. Even though IPhA may accredit
an activity for technicians, it is the technician’s
responsibility to determine whether the subject ma
tter is acceptable to the Pharmacy Technician
Certification Board (PTCB) for recertification.
If all requirements are met, participants will rece
ive continuing pharmacy education credit in the fol
lowing manner. Partial credit will not be awarded.
Please allow 60 days for processing.
Continuing education credit will be earned based on participation in each activity.  Attendees must attend the entire conference, successfully answer the two post-test questions and complete an activity evaluation in order to earn continuing education credit.  The conference comprises six separate activities, and attendees will receive credit for only those activities that they successfully complete.
 
Please allow 60 days for processing continuing education credit following the conference.

Support/Credits

This conference is presented in collaboration with the Society of Palliative Care Pharmacists.  The Society is an organization for pain and palliative care pharmacist practitioners.

 

 

Registration Closed  

Recommendations for appropriate acetaminophen use in chronic liver disease patients are complicated by a lack of consensus from professional organizations.
The goal of this activity is to critically evaluate the quality of evidence from professional organizations and reviews used to formulate the acetaminophen prescribing recommendations in cirrhosis patients. 
The intent of the activity is to change acetaminophen prescribing patterns in cirrhosis.  Due to the nature of this activity and national audience it is not feasible to measure change in acetaminophen recommendations.  

Objectives

  • Review the evidence supporting reduced acetaminophen doses in cirrhosis patients.
  • Apply the clinical evidence to formulate a patient specific recommendation for use of acetaminophen in cirrhosis.

Speaker(s)/Author(s)

Anne Schweighardt picture

Anne Schweighardt, Pharm.D., BCPS
Assistant Professor, St. John Fisher College Wegmans School of Pharmacy


Brief Bio : Dr. Schweighardt received her Pharm.D. from the University of Utah in 2009. She completed an integrated two-year pharmacotherapy residency at Texas Tech University Health Sciences Center in Lubbock, Texas. In August of 2011 she joined the faculty of Wegmans School of Pharmacy. Dr. Schweighardt is an associate professor at St. John Fisher College and maintains a practice site with internal medicine at the University of Rochester Medical Center (URMC) - Strong Memorial Hospital. She is a Board Certified Pharmacotherapy Specialist.
Disclosure : Anne Schweighardt has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.
Katherine Juba picture

Katherine Juba, Pharm.D., BCPS
Associate Professor, Wegmans School of Pharmacy,St. John Fisher College


Brief Bio : Dr. Juba is an associate professor at St. John Fisher College in Rochester, NY. She received her Pharm.D. from the University of Buffalo (UB) and completed a pharmacy practice residency at UB/Niagara Hospice. After her residency she was a pain and palliative clinical pharmacy specialist for three years at Suncoast Hospice in Pinellas County, FL. Dr. Juba's teaching site for third and fourth year pharmacy students is with the palliative care team at the University of Rochester Medical Center (URMC)-Strong Memorial Hospital. She is a Board Certified Pharmacotherapy Specialist. Her research interests focus on pain management and hospice/palliative care pharmacotherapy.
Disclosure : Katherine Juba has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.

Activity Number

0480-9999-18-006-L01-P
Date: 07/17/18
Time: 02:00 PM - 02:30 PM

CE Hours

0.50

Location

Virtual - Online
Registration Closed  

Registration Closed  

Synthetic opioid derivatives of fentanyl, such as carfentanil, are emerging public health threats that pharmacists require an update to their clinical practice during this opioid crisis.
The educational goal is to provide a clinical update on synthetic fentanyl analogs and to improve patient safety by describing best practice management in the community and for pharmacists. 

Objectives

  • Identify the illicit trade routes and risks of illicit fentanyl laced heroin
  • Describe best practices in response to illicit fentanyl overdoses

Speaker(s)/Author(s)

Sandra DiScala picture

Sandra DiScala, Pharm.D., BCPS.
West Palm Beach VAMC


Brief Bio : Dr. Sandra DiScala is a clinical pharmacy specialist at the West Palm Beach VAMC. She is a Board Certified Pharmacotherapy Specialist. Her clinical practice site includes advanced practice pharmacy care through management of the PharmD-run inpatient pain consult service, symptom management for the inpatient hospice unit, short-term rehab and long term care consultant pharmacy services, and consultative expertise in an outpatient palliative care clinic. She received her Pharm.D. degree from Nova Southeastern University with honors in West Palm Beach, Florida, after which she completed a PGY1 residency in pharmacy at the West Palm Beach VAMC. She is also Director of the PGY2 pain management and palliative care pharmacy residency program at the West Palm Beach VAMC. She is a founding member of the Society of Palliative Care Pharmacists and is currently serving as treasurer.
Disclosure : Dr. DiScala has disclosed a financial interest with Indivior PLC. The conflict of interest has been resolved. Contact me if you require additional information.

Activity Number

0480-9999-18-007-L01-P
Date: 07/17/18
Time: 02:30 PM - 03:00 PM

CE Hours

0.50

Location

Virtual - online
Registration Closed  

Registration Closed  

There is a lack of knowledge on how to prevent opioid abuse and manage patients’ pain who are actively abusing substances and those who are recovering from addiction
The educational goal of this activity is to provide principles for managing pain without triggering relapse in patients recovering from substance abuse/addiction. 

Objectives

  • Describe action plans which a recovering individual might use to prevent relapse when facing the need to take opioids.
  • List considerations for prescribing and monitoring for individuals who are recovering addicts and who require opioids.

Speaker(s)/Author(s)

Phyllis Grauer picture

Phyllis Grauer, Pharm.D., BCGP, CPE
ChaRxis Consulting


Brief Bio : Phyllis Grauer, RPh, PharmD has been a pain, palliative care and hospice clinical pharmacist for more than 30 years. She is a Certified Pain Educator (CPE), is Board Certified in Geriatric Pharmacy (BCGP) and is completing her certification as a Chemical Dependency Counselor Assistant. She received her BS in Pharmacy from The Ohio State University College of Pharmacy and her PharmD from Kansas University School of Pharmacy. In addition to developing a nationwide hospice and palliative care clinical consulting company in the past, she has lectured extensively to health care practitioners on topics surrounding pain, palliative care and substance use disorders/addiction. She has also taught at Ohio State University, Cedarville University, Ohio Northern University and University of Findlay Schools of Pharmacy and has multiple publications. In addition to her pain management expertise, Phyllis brings a unique perspective to support the health care team and patients who are either at risk, are struggling with active substance abuse or those individuals who are striving to maintain their recovery as she has been in recovery from addiction triggered by prescribed opioids for the treatment of chronic pain for over 24 years.
Disclosure : Phyllis Grauer has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.

Activity Number

0480-9999-18-008-L01-P
Date: 07/17/18
Time: 03:00 PM - 03:30 PM

CE Hours

0.50

Location

Virtual
Registration Closed  

Registration Closed  

Lack of formal training and regular interface with the sickle cell population leaves most healthcare practitioners feeling ill-prepared to best assess and care for this unique patient population. 
Sickle cell disease (SCD) is the most common inherited blood disorder in the United States, affecting approximately 100,000 Americans. Despite the fact that medical advances are ensuring that those with SCD are living longer, their quality of life is not necessarily improvedand the care they receive is inconsistent.  As a result, caring for these people is often a complex and challenging task for most providers and it can elicit a reflexive “groan” from even the most caring team members.  Pain management and palliative care teams are increasingly being asked to help care for people with SCD.  Pharmacists on these teams have the capacity to guide optimal care, inform and educate healthcare providers and patients, assess and recommend pertinent interventions, and ultimately optimize the quality of life of the sickle cell patients they encounter. This session would aim to provide an overview of sickle cell disease and common causes of morbidity and mortality. Additionally, it will focus on unique complexities of this patient population and opportunities for the pain management and palliative care provider to optimize quality of life.  

Objectives

  • Describe sickle cell disease and the most common causes of morbidity and mortality in this patient population
  • Summarize the unique complexities of sickle cell disease treatment and opportunities to optimize patient care via pain management and palliative care interventions

Speaker(s)/Author(s)

Rabia Atayee picture

Rabia Atayee, Pharm.D., BCPS
Prof. Pharmacy and Palliative Care Physician, UC San Diego Skaggs School of Pharmacy


Brief Bio : Dr. Rabia Atayee is the Associate Dean for Admissions and Outreach at UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences (SSPPS). She is also an Associate Professor of Clinical Pharmacy at SSPPS where she is actively involved in clinical, research, teaching, and external national activities with a focus in palliative care. Dr. Atayee is a board-certified pharmacotherapy specialist with expertise in palliative care. She has developed her role and the presence of a pharmacist on the palliative care team at UC San Diego Health System under a Collaborative Practice Protocol that has been approved and credentialed to practice under expanded scope of practice within the health system. She is the first pharmacist in southern California to obtain a DEA license and has the authority to initiate controlled substances for the treatment of her palliative care patients. Her clinical expertise and excellence in patient care is exemplified by the growth of her clinical practice. Dr. Atayee’s major research focus is in the area of palliative care with a minor research focus in the area of pharmacy education. She has established several collaborations across disciplines and nationally with other faculty. As a life-long learner herself, she takes pride in teaching and mentoring pharmacy and medical students, residents and fellows. At UC San Diego, she has consistently achieved teaching excellence as documented in her evaluations in the classroom and on clinical rotations. In 2013 she was nominated by the Deans of UC San Diego SSPPS and presented with the American Association of Colleges of Pharmacy (AACP) Teacher of the Year Award, in 2014 she was awarded UC San Diego SSPPS Teacher of the Year Award by the class of 2017 and in 3018 she was awarded the UC San Diego campus-wide distinguished teaching award. Dr. Atayee has collaborated and presented with various colleagues at national conferences.
Disclosure : Rabia Atayee has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.

Stephanie Abel, Pharm.D., BCPS.
The Ohio State University Wexner Medical Center -


Brief Bio : Stephanie Abel is a Clinical Pharmacy Specialist in Palliative Medicine at The Ohio State University Wexner Medical Center – James Cancer Hospital. She rotates between the inpatient palliative consult service and the benign hematology service. She received her PharmD from Creighton University in Omaha, Nebraska after which she completed a PGY-1 in Pharmacy Practice at The Medical University of South Carolina in Charleston, SC and a PGY-2 in Pain Management and Palliative Care at The Johns Hopkins Hospital in Baltimore, MD. Caring for patients with sickle cell disease is a passion for Stephanie. In addition to rounding on the inpatient sickle cell service and staffing the multidisciplinary sickle cell clinic monthly, she is currently leading a project for opioid/pain stewardship in this population at The Ohio State University Wexner Medical Center. Stephanie is a primary preceptor for multiple disciplines and a reviewer for the Journal of the American College of Clinical Pharmacy and the Journal of Oncology Pharmacy Practice. Stephanie is the current Chair-Elect of the American College of Clinical Pharmacy Pain and Palliative Care Practice and Research Network as well as the Chair of the Nominations Committee for the Society of Palliative Care Pharmacists. In 2016, Stephanie was appointed by Governor John Kasich to sit on the Medical Marijuana Advisory Committee for the state of Ohio due to her specialized medical knowledge on the subject where she continues to serve. Additionally, she has assisted the various Ohio state departments in the creation of rules surrounding medical marijuana program implementation, platform functionality requests, etc.
Disclosure : Stephanie Abel has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.
Toluwalase Ajayi picture

Toluwalase Ajayi, MD
UCSD Rady Children's Hospital


Brief Bio : Toluwalase (Lase) Ajayi is a fellowship trained palliative care physician and pediatrician. She is dedicated to expanding the benefits of palliative medicine across all ages, as well as improving communication with seriously ill patients. She has a strong interest in studying methods of improving communication between seriously ill patients and hospital teams; as well as investigating how palliative medicine can improve the quality of lives of patients with previously devastating pediatric disease who are now living well into adulthood. This group of patients includes, but is not limited to, those with congenital heart defects, cystic fibrosis, and hemoglobinopathies as well as survivors of pediatric cancers. She currently serves as the medical director of palliative medicine at Scripps Mercy hospital San Diego, an Assistant Professor of Pediatrics at UCSD, works as a hospitalist and palliative medicine physician at Rady Children’s Hospital, is a clinical researcher at The Scripps Research Institute and is the Director of Diversity Initiatives at the Scripps Translational Science Institute. She is well published in her work with patients with serious illnesses. She completed medical school and residency at the University of Kansas and moved to San Diego for fellowship in Hospice and Palliative Medicine.
Disclosure : Toluwalase Ajayi has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.

Activity Number

0480-9999-18-009-L01-P
Date: 07/17/18
Time: 03:30 PM - 04:00 PM

CE Hours

0.50

Location

Virtual
Registration Closed  

Registration Closed  

Pain, palliative care and hospice (PPCH) teams specialize in providing whole person care for patients diagnosed with serious medical illnesses.  There are a set of step-wise approaches that multidisciplinary palliative care teams utilize in their assessment and treatment of complex pain.  When initial treatment approaches are not successful, PPCH pharmacists are often asked to lead treatment of these refractory cases with their expertise in medication pharmacology in the setting of inadequate supporting literature.  In this session we will discuss a case to highlight refractory total pain and promote the use of lidocaine infusion for refractory pain syndromes and conversion of lidocaine to mexiletine for home use.  

Objectives

  • Discuss transitioning complex inpatient treatment approaches to a feasible discharge plan.
  • Discuss use of lidocaine refractory pain syndromes and conversion to mexiletine.

Speaker(s)/Author(s)

Kyle Edmonds picture

Kyle Edmonds, MD
Health Sciences Clinical Assistant Professor, UC San Diego


Brief Bio : Publications on sickle cell disease, methadone, dexamethasone, palliative pharmacy, primary palliative education, tramadol, ECMO & palliative care, delirium, and goals of care.
Disclosure : Kyle Edmonds has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.
Rabia Atayee picture

Rabia Atayee, Pharm.D., BCPS
Prof. Pharmacy and Palliative Care Physician, UC San Diego Skaggs School of Pharmacy


Brief Bio : Dr. Rabia Atayee is the Associate Dean for Admissions and Outreach at UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences (SSPPS). She is also an Associate Professor of Clinical Pharmacy at SSPPS where she is actively involved in clinical, research, teaching, and external national activities with a focus in palliative care. Dr. Atayee is a board-certified pharmacotherapy specialist with expertise in palliative care. She has developed her role and the presence of a pharmacist on the palliative care team at UC San Diego Health System under a Collaborative Practice Protocol that has been approved and credentialed to practice under expanded scope of practice within the health system. She is the first pharmacist in southern California to obtain a DEA license and has the authority to initiate controlled substances for the treatment of her palliative care patients. Her clinical expertise and excellence in patient care is exemplified by the growth of her clinical practice. Dr. Atayee’s major research focus is in the area of palliative care with a minor research focus in the area of pharmacy education. She has established several collaborations across disciplines and nationally with other faculty. As a life-long learner herself, she takes pride in teaching and mentoring pharmacy and medical students, residents and fellows. At UC San Diego, she has consistently achieved teaching excellence as documented in her evaluations in the classroom and on clinical rotations. In 2013 she was nominated by the Deans of UC San Diego SSPPS and presented with the American Association of Colleges of Pharmacy (AACP) Teacher of the Year Award, in 2014 she was awarded UC San Diego SSPPS Teacher of the Year Award by the class of 2017 and in 3018 she was awarded the UC San Diego campus-wide distinguished teaching award. Dr. Atayee has collaborated and presented with various colleagues at national conferences.
Disclosure : Rabia Atayee has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.

Activity Number

0480-9999-18-010-L01-P
Date: 07/17/18
Time: 04:10 PM - 04:40 PM

CE Hours

0.50
Registration Closed  

Registration Closed  

Given the nationwide opioid shortage, pharmacists and clinicians are having to utilize lesser known opioids to manage pain. Pharmacists and clinicians are often less experienced with these medications and this activity seeks to provide updates and guidance on best practices. 

 

The educational goal of this activity is to provide background and describe strategies to manage acute or severe pain in the face of parenteral opioid shortages that clinicians can utilize in their practice. 

Participants will identify the appropriate safety and management strategies given a patient case.

 


 

Objectives

  • Explain recent trends related to the shortage of parenteral opioids
  • Identify best practices and possible alternatives to mitigate the impact of parenteral opioid shortages.

Speaker(s)/Author(s)

Ryan Constantino picture

Ryan Constantino, Pharm.D, BCPS, BCGP
University of Maryland School of Pharmacy


Brief Bio : Ryan Costantino, PharmD, is a PGY2 Pain and Palliative Care Pharmacy Resident at the University of Maryland School of Pharmacy. He is also an active duty Army pharmacist. He received his Doctor of Pharmacy degree from the Massachusetts College of Pharmacy. He completed a PGY-1 pharmacy practice residency at the University of Maryland Medical Center and is a board-certified pharmacotherapy, and geriatric specialist. His professional interests include Pain Management, Palliative Care, and Patient Centered Outcomes Research.
Disclosure : Ryan Constantino has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.

Activity Number

0480-9999-18-011-L01-P
Date: 07/17/18
Time: 04:40 PM - 05:00 PM

CE Hours

0.50

Location

Virtual
Registration Closed